 India-based Dr Reddys Laboratories Ltd NYSE: RDY will launch its generic version of Merck Co Incs NYSE: MRK COVID-19 antiviral pill, reported Reuters. A company spokesperson said Reddys would launch the molnupiravir generic at 35 0.4693 per capsule. 